Cargando…
IL-21 drives expansion and plasma cell differentiation of autoreactive CD11c(hi)T-bet(+) B cells in SLE
Although the aetiology of systemic lupus erythematosus (SLE) is unclear, dysregulated B cell responses have been implicated. Here we show that an unusual CD11c(hi)T-bet(+) B cell subset, with a unique expression profile including chemokine receptors consistent with migration to target tissues, is ex...
Autores principales: | Wang, Shu, Wang, Jingya, Kumar, Varsha, Karnell, Jodi L., Naiman, Brian, Gross, Phillip S., Rahman, Saifur, Zerrouki, Kamelia, Hanna, Richard, Morehouse, Christopher, Holoweckyj, Nicholas, Liu, Hao, Manna, Zerai, Goldbach-Mansky, Raphaela, Hasni, Sarfaraz, Siegel, Richard, Sanjuan, Miguel, Streicher, Katie, Cancro, Michael P., Kolbeck, Roland, Ettinger, Rachel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5931508/ https://www.ncbi.nlm.nih.gov/pubmed/29717110 http://dx.doi.org/10.1038/s41467-018-03750-7 |
Ejemplares similares
-
LOX-1: A potential driver of cardiovascular risk in SLE patients
por: Sagar, Divya, et al.
Publicado: (2020) -
Using the circulating proteome to assess type I interferon activity in systemic lupus erythematosus
por: Smith, Michael A., et al.
Publicado: (2020) -
Low-density granulocytes activate T cells and demonstrate a non-suppressive role in systemic lupus erythematosus
por: Rahman, Saifur, et al.
Publicado: (2019) -
SLE Plasma Profiling Identifies Unique Signatures of Lupus Nephritis and Discoid Lupus
por: Smith, Michael A., et al.
Publicado: (2019) -
Characterisation of anifrolumab, a fully human anti-interferon receptor antagonist antibody for the treatment of systemic lupus erythematosus
por: Riggs, Jeffrey M, et al.
Publicado: (2018)